These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26114354)

  • 1. Resveratrol via activation of AMPK lowers blood pressure in DOCA-salt hypertensive mice.
    Sun GQ; Li YB; Du B; Meng Y
    Clin Exp Hypertens; 2015; 37(8):616-21. PubMed ID: 26114354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.
    Cao X; Luo T; Luo X; Tang Z
    Hypertens Res; 2014 Sep; 37(9):803-10. PubMed ID: 24965170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the AMP-activated protein kinase-α2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice.
    Wang S; Liang B; Viollet B; Zou MH
    Hypertension; 2011 May; 57(5):1010-7. PubMed ID: 21464390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine-induced AMP-activated protein kinase activation attenuates vasoconstriction through an LKB1-dependent mechanism in rat aorta.
    Lee KY; Choi HC
    Vascul Pharmacol; 2013; 59(3-4):96-102. PubMed ID: 23916920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin-induced AMP-activated protein kinase activation regulates phenylephrine-mediated contraction of rat aorta.
    Sung JY; Choi HC
    Biochem Biophys Res Commun; 2012 May; 421(3):599-604. PubMed ID: 22525678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol via activation of LKB1-AMPK signaling suppresses oxidative stress to prevent endothelial dysfunction in diabetic mice.
    Hu M; Liu B
    Clin Exp Hypertens; 2016; 38(4):381-7. PubMed ID: 27149559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin-Induced AMP-Activated Protein Kinase Activation Attenuates Vasoconstriction Through LKB1-AMPK Signaling Pathway.
    Kim SG; Kim JR; Choi HC
    J Med Food; 2018 Feb; 21(2):146-153. PubMed ID: 29035613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol lowers blood pressure in spontaneously hypertensive rats via calcium-dependent endothelial NO production.
    Li X; Dai Y; Yan S; Shi Y; Li J; Liu J; Cha L; Mu J
    Clin Exp Hypertens; 2016; 38(3):287-93. PubMed ID: 27018796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preserved expression of GLUT4 prevents enhanced agonist-induced vascular reactivity and MYPT1 phosphorylation in hypertensive mouse aorta.
    Atkins KB; Prezkop A; Park JL; Saha J; Duquaine D; Charron MJ; Olson AL; Brosius FC
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H402-8. PubMed ID: 17369465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of AMPK/proteasome/MLCK degradation signaling axis by telmisartan inhibits VSMC contractility and vessel contraction.
    Hwang YJ; Cho DH
    Biochem Biophys Res Commun; 2020 Apr; 524(4):853-860. PubMed ID: 32046856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol regulates blood pressure by enhancing AMPK signaling to downregulate a Rac1-derived NADPH oxidase in the central nervous system.
    Yeh TC; Shin CS; Chen HH; Lai CC; Sun GC; Tseng CJ; Cheng PW
    J Appl Physiol (1985); 2018 Jul; 125(1):40-48. PubMed ID: 29494287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
    Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
    Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
    Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
    J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38 mitogen-activated protein kinase contributes to the diminished aortic contraction by endothelin-1 in DOCA-salt hypertensive rats.
    Kim B; Kim J; Bae YM; Cho SI; Kwon SC; Jung JY; Park JC; Ahn HY
    Hypertension; 2004 May; 43(5):1086-91. PubMed ID: 15051668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol Inhibition of Rac1-Derived Reactive Oxygen Species by AMPK Decreases Blood Pressure in a Fructose-Induced Rat Model of Hypertension.
    Cheng PW; Lee HC; Lu PJ; Chen HH; Lai CC; Sun GC; Yeh TC; Hsiao M; Lin YT; Liu CP; Tseng CJ
    Sci Rep; 2016 May; 6():25342. PubMed ID: 27138844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice.
    Goirand F; Solar M; Athea Y; Viollet B; Mateo P; Fortin D; Leclerc J; Hoerter J; Ventura-Clapier R; Garnier A
    J Physiol; 2007 Jun; 581(Pt 3):1163-71. PubMed ID: 17446219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of AMP-activated protein kinase by metformin ablates angiotensin II-induced endoplasmic reticulum stress and hypertension in mice in vivo.
    Duan Q; Song P; Ding Y; Zou MH
    Br J Pharmacol; 2017 Jul; 174(13):2140-2151. PubMed ID: 28436023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant endoplasmic reticulum stress in vascular smooth muscle increases vascular contractility and blood pressure in mice deficient of AMP-activated protein kinase-α2 in vivo.
    Liang B; Wang S; Wang Q; Zhang W; Viollet B; Zhu Y; Zou MH
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):595-604. PubMed ID: 23288166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.
    Dai SY; Peng W; Zhang YP; Li JD; Shen Y; Sun XF
    J Neuroinflammation; 2015 Mar; 12():47. PubMed ID: 25885968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
    Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
    Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.